Table 4.
Partial Correlations (95% CI) Between VO2peak (mL/kg FFM/min) (n = 20) or Delta Efficiency (n = 29) and Body Composition and Cardiometabolic Health Markers, Controlling for Age, Sex, and Race
| Measure | VO2peak (mL/kg FFM/min) | Delta efficiency |
|---|---|---|
| Fat mass index | −.19 (−.64 to .36) | .44* (.05 to .71) |
| %BF | −.16 (−.62 to .38) | .40* (.01 to .69) |
| Abdominal VATa | −.36 (−.74 to .19) | .22 (−.19 to .57) |
| Abdominal SATa | −.44 (−.78 to .09) | .38 (−.02 to .67) |
| Systolic BP | −.18 (−.63 to .37) | −.06 (−.45 to .34) |
| Diastolic BP | −.46 (−.79 to .07) | .10 (−.31 to .48) |
| HOMA-IR | .00 (−.51 to .51) | −.16 (−.52 to .25) |
| LDL-C | −.08 (−.57 to .45) | −.21 (−.56 to .20) |
| HDL-C | .05 (−.47 to .55) | .12 (−.29 to .49) |
| TRIG | −.29 (−.70 to .26) | −.07 (−.45 to .33) |
| hsCRP | .03 (−.49 to .53) | .48* (.11 to .74) |
| Cardiometabolic risk score | −.37 (−.74 to .18) | .00 (−.39 to .40) |
Abbreviations: BP, blood pressure; CI, confidence interval; FFM, fat-free mass; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin resistance; hsCRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; SAT, subcutaneous adipose tissue; TRIG, triglycerides; VAT, visceral adipose tissue; VO2peak, peak aerobic capacity; %BF, percentage body fat.
Note: Bolded values reached statistical significance
*
P < .05.
a
n = 18/27 due to poor quality MRI data in 2 participants.